Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis
- PMID: 28399488
- PMCID: PMC5500311
- DOI: 10.1016/j.addbeh.2017.04.006
Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis
Abstract
Background: No effective pharmacotherapies exist for the treatment of crack cocaine use disorders. Emerging data suggests that cannabinoids may play a role in reducing cocaine-related craving symptoms. This study investigated the intentional use of cannabis to reduce crack use among people who use illicit drugs (PWUD).
Methods: Data were drawn from three prospective cohorts of PWUD in Vancouver, Canada. Using data from participants reporting intentional cannabis use to control crack use, we used generalized linear mixed-effects modeling to estimate the independent effect of three pre-defined intentional cannabis use periods (i.e., before, during and after first reported intentional use to reduce crack use) on frequency of crack use.
Results: Between 2012 and 2015, 122 participants reported using cannabis to reduce crack use, contributing a total of 620 observations. In adjusted analyses, compared to before periods, after periods were associated with reduced frequency of crack use (Adjusted Odds Ratio [AOR]=1.89, 95% Confidence Interval [CI]: 1.02-3.45), but not the intentional use periods (AOR=0.85, 95% CI: 0.51-1.41). Frequency of cannabis use in after periods was higher than in before periods (AOR=4.72, 95% CI: 2.47-8.99), and showed a tendency to lower frequency than in intentional cannabis use periods (AOR=0.56, 95% CI: 0.32-1.01).
Conclusions: A period of intentional cannabis use to reduce crack use was associated with decreased frequency of crack use in subsequent periods among PWUD. Further clinical research to assess the potential of cannabinoids for the treatment of crack use disorders is warranted.
Keywords: Cannabidiol; Cannabinoids; Cannabis; Crack cocaine; People who use drugs; Δ9-tetrahydrocannabinol.
Copyright © 2017. Published by Elsevier Ltd.
Conflict of interest statement
Figures
Similar articles
-
Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada.Drug Alcohol Rev. 2018 Jul;37(5):645-652. doi: 10.1111/dar.12815. Epub 2018 Jun 5. Drug Alcohol Rev. 2018. PMID: 29873125 Free PMC article.
-
Risky and rushed public crack cocaine smoking: the potential for supervised inhalation facilities.BMC Public Health. 2016 Jun 7;16:476. doi: 10.1186/s12889-016-3137-3. BMC Public Health. 2016. PMID: 27266703 Free PMC article.
-
Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.Drug Alcohol Depend. 2016 Nov 1;168:211-218. doi: 10.1016/j.drugalcdep.2016.09.013. Epub 2016 Sep 20. Drug Alcohol Depend. 2016. PMID: 27701042 Free PMC article.
-
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.J Neuroimmune Pharmacol. 2015 Jun;10(2):281-92. doi: 10.1007/s11481-014-9575-8. Epub 2014 Dec 24. J Neuroimmune Pharmacol. 2015. PMID: 25537576 Review.
-
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Headache. 2015 Jun;55(6):885-916. doi: 10.1111/head.12570. Epub 2015 May 25. Headache. 2015. PMID: 26015168 Review.
Cited by
-
Smoked cannabis reduces peak cocaine plasma levels and subjective effects in a controlled drug administration study of polysubstance use in men.Drug Alcohol Depend. 2023 Feb 1;243:109757. doi: 10.1016/j.drugalcdep.2022.109757. Epub 2022 Dec 29. Drug Alcohol Depend. 2023. PMID: 36608482 Free PMC article. Clinical Trial.
-
"Everything is kind of the same except my mind is with me": exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction.Harm Reduct J. 2024 Apr 20;21(1):83. doi: 10.1186/s12954-024-01002-0. Harm Reduct J. 2024. PMID: 38643152 Free PMC article.
-
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.Psychopharmacology (Berl). 2022 May;239(5):1211-1230. doi: 10.1007/s00213-021-05960-2. Epub 2021 Oct 6. Psychopharmacology (Berl). 2022. PMID: 34613429 Free PMC article.
-
Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada.Cannabis. 2024 Jun 26;7(2):135-149. doi: 10.26828/cannabis/2024/000208. eCollection 2024. Cannabis. 2024. PMID: 38975599 Free PMC article.
-
Interaction Between Stress and Addiction: Contributions From Latin-American Neuroscience.Front Psychol. 2018 Dec 21;9:2639. doi: 10.3389/fpsyg.2018.02639. eCollection 2018. Front Psychol. 2018. PMID: 30622500 Free PMC article. Review.
References
-
- Aharonovich E, Liu X, Samet S, Nunes E, Waxman R, Hasin D. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. Am J Psychiatry. 2005;162(8):1507–1514. - PubMed
-
- de Carvalho CR, Takahashi RN. Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats. Addict Biol 2016 - PubMed
-
- De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am J Epidemiol. 1996;143(7):725–732. - PubMed
-
- DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T. Public injecting among a cohort of injecting drug users in Vancouver, Canada. J Epidemiol Community Health. 2009;63(1):81–86. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical